Investors May Lead Class Action Against Humacyte, Inc. Over Securities Fraud

LOS ANGELES, Dec. 2, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz has announced that investors who experienced significant losses now have the opportunity to act as lead plaintiffs in a class action lawsuit concerning Humacyte, Inc. (“Humacyte” or the “Company”) HUMA.

Class Period: May 10, 2024 – October 17, 2024
Lead Plaintiff Deadline: January 17, 2025

Shareholders who suffered losses during this period are encouraged to participate.

The complaint claims that the Company’s management failed to reveal several key facts to investors. These include: (1) the Company’s facility in Durham, North Carolina did not meet good manufacturing practices, particularly in quality assurance and microbial testing; (2) the FDA’s review of the Biologics License Application (BLA) would face delays due to these issues; (3) there was a significant risk that FDA approval for ATEV for treating vascular trauma could be jeopardized; and (4) as a result, the positive statements made by the Company about its business prospects were misleading or not based on solid ground.

For updates, follow us on Twitter: twitter.com/FRC_LAW.

To be part of the class action, no immediate action is necessary. Interested parties may retain legal counsel or choose to remain absent from the lawsuit. For further details about the class action, or any inquiries regarding this announcement and your rights, please reach out to Frank R. Cruz at The Law Offices of Frank R. Cruz, located at 2121 Avenue of the Stars, Suite 800, Century City, California 90067. You can call at 310-914-5007, email at info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If contacting via email, please provide your mailing address, phone number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under applicable law and ethical guidelines.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/huma-investors-have-opportunity-to-lead-humacyte-inc-securities-fraud-lawsuit-302319961.html

SOURCE The Law Offices of Frank R. Cruz, Los Angeles